Overview

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
To compare the antidepressant efficacy and safety of subjects receiving DVS-233 SR versus subjects receiving placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer